Minimize interference in your LF immunoassays exploiting UCNPs

Upconverting nanoparticles (UCNPs) as a measurement technology enables more sensitive results to your diagnostic assays. Our upcoming biotech company offers these UCNP – particles and readers as a part of its product portfolio. The new company, including three frontrunners in the field, will provide a total solution for point-of-care testing. Anywhere and at any time! Stay tuned for updates. Labrox already provides a UPCON […]

Upcon technology brings new opportunities in the life science field

Is your assay lacking sensitivity? Do you need a lower detection limit for your lateral flow based assay? Let us introduce a new label technology based on upconverting nanoparticles (UCNPs). The market demand for more sensitive point-of-care assays seems to be strong nowadays. Upcon®, a concept by Kaivogen Oy and Labrox Oy, was then developed further to answer this demand. […]

Labrox will be attending UPCONline 2021

Labrox is one of the sponsors for UPCONline 2021 that will be held from 6th to 9th April this year. The conference is available via Zoom online, due to the pandemic. Our head of diagnostic devices, Ida Erling, will represent Labrox at UPCONline with a speech titled “Upcon®: readers and particles for sensitive lateral flow assays”. Find out more & book your […]

Power of teamwork

We at Labrox believe that the real power of new inventions originates from teamwork. Having put this motto into practice, we are now ready to introduce a new line of commercial products developed from novel research made at the University of Turku. During the past year, we have been working together with the University of Turku along with an impressive […]